The use of regional coordinating centers in large clinical trials: the DIG trial

被引:9
|
作者
Collins, JE
Martin, S
Kent, E
Liuni, C
Garg, R
Egan, D
机构
[1] Cooperat Studies Program Coordinating Ctr, VA Maryland Hlth Care Syst, Dept Vet Affairs, Perry Point, MD 21902 USA
[2] Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[3] Univ Alberta, Edmonton, AB, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 06期
关键词
randomized clinical trials; large simple trial; heart failure; digoxin; regional coordinating centers;
D O I
10.1016/S0197-2456(03)00101-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Digitalis Investigation Group (DIG) trial was a large simple clinical trial that involved 302 participating centers in the United States and Canada. In order to encourage participation by Canadian investigators, to provide additional help to what were expected to be largely research-inexperienced investigators in Canada, and to provide the study's data coordinating center with resources in Canada to deal with potentially different rules, regulations, and cultural differences, regional coordinating centers were established in four regions of Canada: the maritime provinces, Quebec, Ontario, and western Canada. Canadian centers recruited significantly better than their U.S. counterparts and had slightly better retention and follow-up. While it is not possible to declare that the regional coordinating centers were responsible for this improvement, it is believed that these regional centers did play a role. This role included being able to identify investigators who could be expected to do well, providing one-on-one training and instruction to investigators, and being able to solve problems and implement change in the relatively fewer centers in their regions. The regional coordinating center also reduced the intensity of the workload on the data coordinating center by serving as the primary point of contact for Canadian investigators. The use of regional coordinating centers in studies with a large number of participating centers is highly recommended. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:298S / 305S
页数:8
相关论文
共 50 条
  • [31] Digoxin use and digoxin toxicity in the post-DIG Trial era
    Hussain, Z
    Swindle, J
    Hauptman, PJ
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (05) : 343 - 346
  • [32] RESEARCH GOVERNANCE FOR REGIONAL CLINICAL TRIALS
    Robinson, Sandra
    Hayes, Theresa M.
    Hennig, Marcelle
    Woollett, Anne
    Collins, Ian M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 151 - 151
  • [33] The large clinical statin trials
    Agewall, S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 108 - 111
  • [34] Coordinating and monitoring multisite clinical trials that combine pharmacological and behavioral treatments
    Youngblood, ME
    Murray, KT
    Devine, E
    Latham, PK
    Hubatch, S
    JOURNAL OF STUDIES ON ALCOHOL, 2005, : 82 - 91
  • [35] MANAGEMENT OF A COORDINATING CENTER FOR MULTI-CENTER CLINICAL-TRIALS
    CHAN, YK
    COLLINS, D
    CONTROLLED CLINICAL TRIALS, 1981, 2 (01): : 88 - 88
  • [36] Use of Random Effect Models in the Design and Analysis of Multi-regional Clinical Trials
    Wu, Yuh-Jenn
    Tan, Te-Sheng
    Chow, Shein-Chung
    Hsiao, Chin-Fu
    TOPICS IN APPLIED STATISTICS, 2013, 55 : 325 - 334
  • [37] Coordinating data monitoring committees and adaptive clinical trial designs
    Herson, Jay
    DRUG INFORMATION JOURNAL, 2008, 42 (04): : 297 - 301
  • [38] Capability evaluation of a large regional clinical trials unit to assess growth over time.
    Bell, Lisa Ann
    Pitman, Ethan
    Goss, Carmel
    Clarke, Ashleigh
    Gurnett, Rebecca
    Murphy, Virginia
    Chong, Geoffrey
    Faisal, Wasek
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs
    Jay Herson
    Drug information journal : DIJ / Drug Information Association, 2008, 42 (4): : 297 - 301
  • [40] Barriers to Recruitment and Retention Among Underrepresented Populations in Cancer Clinical Trials: A Qualitative Study of the Perspectives of Clinical Trial Research Coordinating Staff at a Cancer Center
    Yousafi, Sumbul
    Rangachari, Pavani
    Holland, Margaret L.
    JOURNAL OF HEALTHCARE LEADERSHIP, 2024, 16 : 427 - 441